• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problems Difficult to Advance (2920); Positioning Problem (3009)
Patient Problems Hematoma (1884); Perforation of Vessels (2135); Pericardial Effusion (3271)
Event Date 10/20/2023
Event Type  Injury  
Event Description
It was reported a perforation, hematoma and pericardial effusion occurred.The procedure was cancelled.It was during a watchman left atrial appendage closure (laac) procedure, a versacross connect kit was selected for use.Once the connect kit was placed in watchman sheath in the superior vena cava (svc), it was tough patient anatomy causing with difficulty imaging (transesophageal echocardiogram tee).The physician could not cross the septum and the aorta was perforated.It was noted hematoma and effusion was caused.Patient was given to reverse heparin and hematoma was stabilized.Patient was then sent to the icu to be closely monitored and expected to be fully recovered.The device is not expected to be returned for analysis.Only a hematoma noted around the aorta in 45 degree tee.The patient had rotated heart.There was difficulty getting on to the septum to get across and to visualize tenting prior to rf application.Transseptal puncture was never crossed and could not find the wire after added current to it.The physician never truly crossed the septum.Wire went into the aorta.Everything was pulled back and versacross connect/ sheath were never pushed from the right atrium.There were multiple attempts required to track up / drop down into position on septum.Perforation might have been to anterior.Radio frequency was applied two times one second constant.After the wire could not be found in the left atrium we swept for effusion finding the hematoma on the aorta.Patient was admitted to icu for monitoring and discharged home one day after.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal, qc H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18106328
MDR Text Key327785838
Report Number2124215-2023-62933
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age69 YR
Patient SexFemale
Patient RaceWhite
-
-